Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk

Drug Metabolism Reviews

Volumn 32, Issue 2, 2000, Pages 169-186

  Haseman, J K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENICITY; CONFERENCE PAPER; DATA BASE; NONHUMAN; RODENT;

ANIMALS; BODY WEIGHT; CARCINOGENICITY TESTS; CARCINOGENS; DATABASES, FACTUAL; HUMANS; MICE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RATS; RISK ASSESSMENT; RODENTIA; SPECIES SPECIFICITY;

EID: 0034036134     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100100570     Document Type: Conference Paper

References (32)

1. J. Huff, J. Cirvello, J. Haseman, and J. Bucher, Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents, Environ. Health Perspect., 93, 247-270 (1991).
2. V. Fung, J. Barrett, and J. Huff, The carcinogenesis bioassay in perspective: Application in identifying human hazards, Environ. Health Perspect., 103, 680-683 (1995).
3. J. E. Huff, Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans, in Testing, Predicting, and Interpreting Chemical Carcinogenicity (K. T. Kitchin, ed.), Marcel Dekker, New York, 1999, pp. 21-123.
4. L. S. Gold and T. H. Slone, Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database, J. Toxicol. Environ. Health, 39, 143-157 (1993).
5. D. Y. Lai, K. P. Baetcke, V. T. Vu, J. A. Cotruvo, and S. L. Eustis, Evaluation of reduced protocols for carcinogenicity testing of chemicals: Report of a joint EPA/ NIEHS workshop, Regul. Toxicol. Pharmacol., 19, 183-201 (1994).
6. J. K. Haseman, J. R. Hailey, and R. W. Morris, Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two year carcinogenicity studies: A National Toxicology Program update, Toxicol. Pathol., 26, 428-441 (1998).
7. J. K. Haseman and J. E. Huff, Species correlation in long term carcinogenicity studies, Cancer Lett., 37, 125-132 (1987).
8. S. K. Seilkop, The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats, Fundam. Appl. Toxicol., 24, 247-259 (1995).
9. A. Turturro, P. Duffy, and R. W. Hart, The effect of caloric modulation on toxicity studies, in Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies (R. W. Hart, D. A. Neumann, and R. T. Robertson, eds.), International Life Sciences Institute, Washington, DC, 1995, pp. 79-98.
10. J. K. Haseman, E. Young, S. L. Eustis, and J. R. Hailey, Body weight/tumor incidence correlations in long term rodent carcinogenicity studies, Toxicol. Pathol., 25, 256-263 (1997).
11. J. K. Haseman, The National Toxicology Program experience with dietary restriction: Does the manner in which reduced body weight is achieved affect tumor incidence? Int. J. Toxicol., 17(Suppl. 2), 119-134 (1998).
12. G. N. Rao, J. K. Haseman, S. Grumbein, D. D. Crawford, and S. L. Eustis, Growth, body weight, survival, and tumor trends in (C57BL/6 × C3H/HeN) F1 (B6C3F1) mice during a nine-year period, Toxicol. Pathol., 18, 71-77 (1990).
13. J. D. Thurman, T. J. Bucci, R. W. Hart, and A. Turturro, Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats, Toxicol. Pathol, 22, 1-9 (1994).
14. J. K. Haseman, J. Bourbina, and S. L. Eustis, The effect of individual housing and other experimental design factors on tumor incidence in B6C3F1 mice, Fundam. Appl. Toxicol., 23, 44-52 (1994).
15. K. M. Abdo and F. W. Kari, The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be modulated by dietary restriction, Exp. Toxicol. Pathol., 48, 129-137 (1996).
16. J. K. Haseman, Use of statistical decision rules for evaluating laboratory animal carcinogenicity studies, Fundam. Appl. Toxicol., 14, 637-648 (1990).
17. J. K. Haseman and M. R. Elwell, Evaluation of false positive and false negative outcomes in NTP long-term rodent carcinogenicity studies, Risk Anal., 16, 813-820 (1996).
18. K. S. Crump, D. Krewski, and C. Van Landingham, Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program, Environ. Health Perspect., 107, 83-88 (1999).
19. K. Crump, D. Krewski, and Y. Wang, Estimates of the number of liver carcinogens in bioassays conducted by the National Toxicology Program, Risk Anal., 8, 299-308 (1998).
20. J. Haseman and F. Johnson, Analysis of NTP rodent bioassay data for anticarcino-genic effects, Mutat. Res., 350, 131-141 (1996).
21. I. Linkov, R. Wilson, and G. M. Gray, Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects, Toxicol. Sci., 34, 1-9 (1998).
22. I. Linkov, R. Wilson, and G. M. Gray, Weight and survival depression in rodent bioassays with and without tumor decreases, Toxicol. Sci., 43, 10-18 (1998).
23. George Gray, private communication, 1998.
24. Richard Wilson, private communication, 1998.
25. E. E. McConnell, H. A. Solleveld, J. A. Swenberg, and G. A. Boorman, Guidelines for combining neoplasms for evaluation of rodent carcinogenicity studies, J. Natl. Cancer Inst., 76, 283-289 (1986).
26. J. E. Huff, S. L. Eustis, and J. K. Haseman, Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies, Cancer Metast. Rev., 8, 1-21 (1989).
27. E. E. McConnell, Pathology requirements for two-year rodent studies. II. Alternative approaches, Toxicol. Pathol., 11, 65-76 (1983).
28. G. A. Boorman and S. L. Eustis, The Pathology Working Group as a means for assuring pathology quality in toxicological studies, in Managing Conduct and Data Quality of Toxicology Studies (B. K. Hoover, J. K. Baldwin, A. F. Uelner, C. E. Whitmire, C. L. Davies, and D. W. Bristol, eds.), Princeton Scientific, Princeton, NJ, 1986, pp. 271-275.
29. G. A. Boorman, C. A. Montgomery, Jr., S. L. Eustis, M. Wolfe, E. E. McConnell, and J. F. Hardisty, Quality assurance in pathology for rodent carcinogenicity studies, in Handbook of Carcinogen Testing (H. A. Milman and E. K. Weisberger, eds.), Noyes, Park Ridge, NJ, 1985, pp. 345-357.
30. R. S. Chhabra, J. E. Huff, J. Haseman, A. Hall, G. Baskin, and M. Cowan, Antineo-plastic effects of 4-hexylresorcinol in F344 rats and B6C3F1 mice, Fundam. Appl. Toxicol., 11, 685-690 (1988).
31. J. K. Dunnick, M. R. Elwell, and J. K. Haseman, Decreased incidence of spontaneous mammary gland neoplasms in female F344 rats treated with amphetamine, methylphenidate, or codeine, Cancer Lett., 102, 77-83 (1996).
32. M. R. Elwell, J. K. Dunnick, J. R. Hailey, and J. K. Haseman, Chemicals associated with decreases in the incidence of mononuclear cell leukemia in the Fischer rat, Toxicol. Pathol., 24, 238-245 (1996).